Wall Street moves higher as chip stocks rebound

Reuters 

By Shreyashi Sanyal

The Commerce Department slapped the restriction on amid allegations the firm stole intellectual property from Inc and on concerns the firm could flood the market with cheap chips.

Micron rose 1.9 percent, and helped the Philadelphia Index jump 2.63 percent, rebounding after hitting its lowest in over a year on Monday. The was up 0.18 percent.

Chip-gear makers also gained after rose 6.6 percent on strong quarterly results and forecast, helped by strength in its memory business.

"There are investors who have wanted to own chipmakers but have been so fearful because of what happened last week," said Peter Kenny, at Global Markets Advisory Group, in

"These players have been prudently on the sidelines but are now seeing an opportunity to gain exposure to semis."

Industrial stocks rose 0.85 percent, getting a boost after said "a great deal" on trade can be struck with

But he also warned that billions of dollars worth of new tariffs are ready if a deal isn't possible. That echoed the essence of a report on Monday that sent Wall Street tumbling at close.

Tariffs and rising costs are among the factors that have spurred a slew of disappointing forecasts from major industrials, chipmakers and other companies, adding worries over slowing corporate growth to fears of faltering global expansion.

Traders have said the uncertainty over next week's mid-term elections has also been a factor for the recent

"Because the impact of the mid-term elections on equities is so poorly defined, we can see it elevating volatility, if not anything," Kenny said.

At 12:56 p.m. ET, the was up 151.25 points, or 0.62 percent, at 24,594.17, the 500 was up 15.31 points, or 0.58 percent, at 2,656.56. The Composite was up 51.82 points, or 0.73 percent, at 7,102.11.

On the earnings front, shares climbed 1.8 percent after beating quarterly sales estimates, while rival dipped 0.1 percent.

But, reported worse-than-expected third quarter revenue and lowered the top end of its full-year sales forecast as generic competition and drug pricing pressure in the hurt its older drugs business.

surged 25.1 percent after beating quarterly estimates and raising its full-year profit forecast on higher overseas sales and lower expenses. rose 2.5 percent.

was up 0.5 percent, ahead of its quarterly earnings report, which is due after the market closes.

Advancing issues outnumbered decliners by a 1.89-to-1 ratio on the NYSE and by a 1.93-to-1 ratio on the

The index recorded 10 new 52-week highs and 20 new lows, while the recorded 13 new highs and 158 new lows.

(Reporting by in Bengaluru; Editing by and Sriraj Kalluvila)

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, October 30 2018. 22:57 IST